Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 02, 2020 08:30 ET
|
ARCA biopharma, Inc.
Initiation of Phase 2b clinical trial evaluating AB201 as a potential treatment for COVID19 anticipated in fourth quarterTopline data from trial anticipated Q2 2021 WESTMINSTER, Colo., Nov. 02,...
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
October 07, 2020 08:30 ET
|
ARCA biopharma, Inc.
Initiation of Phase 2b clinical trial anticipated in Q4 2020Trial to enroll approximately 100 patients hospitalized with COVID-19Topline data anticipated Q2 2021 WESTMINSTER, Colo., Oct. 07, 2020 ...
Global and United States Anticoagulants Market Size & Forecast Report 2020-2024 with Impact Analysis of COVID-19
September 14, 2020 07:38 ET
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to...
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 05, 2020 16:15 ET
|
ARCA biopharma, Inc.
AB201 being developed as a potential treatment for COVID-19 and other RNA virus associated diseasesARCA anticipates filing an IND for AB201 in Q3 2020 and initiating Phase 2 clinical testing in Q4...
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
May 28, 2020 08:00 ET
|
ARCA biopharma, Inc.
AB201 (rNAPc2) is being developed as a potential treatment for COVID Associated Coagulopathy, a condition characterized by abnormal blood clotting in patients with COVID-19Previous safety data in more...
U.S. FDA Approves Terumo BCT’s Sodium Citrate 4% w/v Anticoagulant Solution Amid Shortage
July 18, 2018 10:04 ET
|
Terumo BCT
Lakewood, Colorado, USA, July 18, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) recently approved Terumo BCT’s Sodium Citrate 4% w/v Anticoagulant Solution USP, indicated for...